Literature DB >> 19619658

Wnt signaling is sufficient to perturb oligodendrocyte maturation.

Keith Feigenson1, Mary Reid, Jill See, E Bryan Crenshaw, Judith B Grinspan.   

Abstract

The development of oligodendrocytes, the myelinating cells of the central nervous system, is temporally and spatially controlled by local signaling factors acting as inducers or inhibitors. Dorsal spinal cord tissue has been shown to contain inhibitors of oligodendrogliogenesis, although their identity is not completely known. We have studied the actions of one family of dorsal signaling molecules, the Wnts, on oligodendrocyte development. Using tissue culture models, we have shown that canonical Wnt activity through beta-catenin activation inhibits oligodendrocyte maturation, independently of precursor proliferation, cell death, or diversion to an alternate cell fate. Mice in which Wnt/beta-catenin signaling was constitutively activated in cells of the oligodendrocyte lineage had equal numbers of oligodendrocyte precursors relative to control littermates, but delayed appearance of mature oligodendrocytes, myelin protein, and myelinated axons during development, although these differences largely disappeared by adulthood. These results indicate that activating the Wnt/beta-catenin pathway delays the development of myelinating oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619658     DOI: 10.1016/j.mcn.2009.07.010

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  83 in total

1.  Wnt signaling and forebrain development.

Authors:  Susan J Harrison-Uy; Samuel J Pleasure
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

2.  Sox10 directs neural stem cells toward the oligodendrocyte lineage by decreasing Suppressor of Fused expression.

Authors:  Christine D Pozniak; Abraham J Langseth; Gerrit J P Dijkgraaf; Youngshik Choe; Zena Werb; Samuel J Pleasure
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

3.  SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells.

Authors:  Li-Jin Chew; Weiping Shen; Xiaotian Ming; Vladimir V Senatorov; Hui-Ling Chen; Ying Cheng; Elim Hong; Susan Knoblach; Vittorio Gallo
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 4.  Controversies in preterm brain injury.

Authors:  Anna A Penn; Pierre Gressens; Bobbi Fleiss; Stephen A Back; Vittorio Gallo
Journal:  Neurobiol Dis       Date:  2015-10-23       Impact factor: 5.996

5.  Dose-dependent regulation of oligodendrocyte specification by β-catenin signaling.

Authors:  Shuhui Sun; Wei Guo; Zunyi Zhang; Mengsheng Qiu; Zhong-Min Dai
Journal:  Neurosci Bull       Date:  2015-03-09       Impact factor: 5.203

Review 6.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

7.  The Ryk receptor is expressed in glial and fibronectin-expressing cells after spinal cord injury.

Authors:  Pau González; Carmen María Fernández-Martos; Ernest Arenas; Francisco Javier Rodríguez
Journal:  J Neurotrauma       Date:  2013-05-09       Impact factor: 5.269

Review 8.  Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives.

Authors:  Hao Huang; Xiao-Feng Zhao; Kang Zheng; Mengsheng Qiu
Journal:  Neurosci Bull       Date:  2013-02-28       Impact factor: 5.203

Review 9.  Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Authors:  Jenna M Gaesser; Sharyl L Fyffe-Maricich
Journal:  Exp Neurol       Date:  2016-03-05       Impact factor: 5.330

Review 10.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.